Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

EMMAC Life Sciences

Biotech & Life Sciences · London, United Kingdom · Founded 2018 Colt

Vertically integrated European medical cannabis and wellness products

Valuation
$100–500M
Latest valuation · 2026
Unlock exact value
Revenue
$50–100M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

1 investor on EMMAC Life Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
Material V

Global footprint

Where EMMAC Life Sciences has talent and traffic

AI talent share
0.6% of workforce is AI talent
(1 of 169 staff)
Core AI00%
Other AI10.59%
Non-AI workforce16899.41%
Workforce by country
🇬🇧 United Kingdom · London HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about EMMAC Life Sciences

An AI-synthesized read of the highest-engagement posts about EMMAC Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See EMMAC Life Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.